June 2022 Issue Table Of Contents

From The Editor

• From Summer Stroll To Summer Hustle

Feature Articles

• Leveling Up By Challenging Assumptions

CEO Corner

• Why Russia’s Invasion Of Ukraine Threatens Our Vibrant Life Science Ecosystem

Companies To Watch

• CinCor Pharma

Industry Research

• Preferred Provider Agreements For Phase 1 Services

Inside The Industry

• Boosting Pipeline Acceleration With A Strategic Pharma/CDMO Relationship
• 4 Steps To A More Resilient/Intelligent Supply Chain
• The Hardest Job In All BioPharma: The CTO
• What Does The Future Hold For China’s Biopharma Industry?
• CoCrystal’s Co-CEOs
• 3 Approaches For Developing Better Drugs To Treat Brain Disorders
• Diversity & Inclusion Through The Eyes Of Two Female Pharma Executives
• Product Launch Success: Getting It Right In Rare Disease
• Building A Successful Internal Innovation Incubator
• Outsourcing Differences By Company Size — Biologic Drug Substance Manufacturing

Leadership Lessons

• Managing For Positive Outcomes During A Period Of Emotional Exhaustion

Ask The Board

• What Should Biopharma Companies With Drugs Moving Into Phase 3 Clinical Trials Prioritize With Respect To Supporting Payer Access In The U.S.?
• What Kinds Of Resources And Assistance Can State-Level Industry Trade Associations Offer Start-Up And Early-Stage Biopharmaceutical Companies?
• What Key Elements Should A Company Consider When Setting Up An Expanded-Access Program For An Experimental Drug Candidate?

2021 CRO Leadership Awards

From The Editor

• Why I’m Thankful For Sponsors And CROs

Feature Article

• Takeda’s Mission To Improve Communication With Patients, Sites, And CROs

Industry Research

• Outsourcers Send A Consistent Message In Phase 2/3 CRO Selection

Inside The Industry

• CRO Oversight Essentials
• Diversity In Clinical Research Execution And Participation
• How To Build A Strong CRO Partnership And Find Drug Development Success

Winners List